Noninvasive Genotyping and Early Disease Dynamics Demonstrate the Efficacy of Ibrutinib in Combination with Immunochemotherapy in Patients with Mantle Cell Lymphoma Treated in the TRIANGLE Trial

By
Noshin Noorjahan
-
0
40
Besides direct anti-B-cell efficacy, ibrutinib improves chemotherapy efficiency by reconstituting an effective immune system and enhancing immune cell control.
[Leukemia]
Full Article